The director of ITIA argues why the cases of Swiatek and Halep are not comparable

Streaming ATP Hamburg live tennis

🎾 Henri Squire vs Cristian Garin

1. Sign up with Bet365 here
2. Make your first deposit of at least €5
3. Go to the “Live” section and watch every match

Watch the match on Bet365

 PUBLICIDAD

Register at bet365, deposit €5 or more into your account and you will receive 100% of your eligible deposit in Bet Credits (up to €100). New customers only. Terms apply. Winnings do not include the value of Bet Credits. Maximum prizes, game restrictions, time limits and terms apply. Registration required.

Great controversies have arisen during 2024 regarding cases of positive doping involving Iga Swiatek, with authorities' management of the situation being perceived as a cause for mistrust by the media and fans. Many have pointed out a preferential treatment towards the Polish player, comparing her case to the severity of the sanctions imposed on Simona Halep.

One institution that has raised doubts among fans and whose reputation may have been tarnished in 2024 is the ITIA. The organization responsible for managing doping in the tennis world has been heavily criticized for how it handled the cases of Jannik Sinner and Iga Swiatek. The appeal by the World Anti-Doping Agency in Sinner's doping case could end up revealing the actions of the ITIA, but its executive director, Karen Moorhouse, addressed the issue in statements to Tennis365.

- Halep took a contaminated supplement, whereas Swiatek's case involved medication.

"The applied rules and procedures have been the same for all players. Each case is different and complex, making it difficult to equate doping cases of different players and make comparisons between them, as details make the difference," she said before addressing Simona Halep's case.

The Romanian has bitterly complained about what she sees as indiscriminate persecution compared to Iga and Jannik. "What happened in both cases is completely different. The CAS determined that Halep took a contaminated collagen supplement, whereas Swiatek's case involved a regulated medication that she regularly takes. The level of guilt and responsibility differs greatly between them, as the Polish player had no way of knowing about that contamination," concluded the ITIA director, responding to the major controversy.

This news is an automatic translation. You can read the original news, La directora de la ITIA argumenta por qué los casos de Swiatek y Halep no son comparables